(Boursier.com) — At the end of the first half of its 2023 financial year, Bio-UV achieved consolidated revenue of €24.1 million, down 14% compared to the first half of 2022.
This change should be analyzed in the light of the very strong growth in activity achieved in the 1st half of 2022 at +75% total growth and +21% organically.
The company aims to achieve a higher turnover in the 2nd half of 2023 than that achieved in the 1st half of 2023.
©2023 Boursier.com